Anti–Immunoglobulin-Like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients With Advanced Solid Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
First-in-Class Anti-Immunoglobulin-Like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1-Resistance Mechanism in Patients With Advanced Solid Tumors
Clin. Cancer Res 2021 Oct 01;[EPub Ahead of Print], LL Siu, D Wang, J Hilton, R Geva, D Rasco, R Perets, AK Abraham, DC Wilson, JF Markensohn, J Lunceford, L Suttner, S Siddiqi, RA Altura, C Maurice-DrorFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.